Agonism of 5-HT1A is neuroprotective in animal models of CNS ischemia, traumatic brain injury, excitotoxicity, Parkinson’s disease, delayed progression of motor neuron degeneration, and reduced lipid peroxidation in a rat epilepsy model. Here, HTR1A is linked to epilepsy.